| 0 |
DRUG INEFFECTIVE |
473 |
| 1 |
OFF LABEL USE |
347 |
| 2 |
AGGRESSION |
193 |
| 3 |
SOMNOLENCE |
182 |
| 4 |
TOXICITY TO VARIOUS AGENTS |
180 |
| 5 |
FATIGUE |
165 |
| 6 |
HYPOTENSION |
162 |
| 7 |
NAUSEA |
154 |
| 8 |
INTENTIONAL OVERDOSE |
151 |
| 9 |
ANXIETY |
148 |
| 10 |
DRUG INTERACTION |
139 |
| 11 |
HEADACHE |
134 |
| 12 |
INSOMNIA |
134 |
| 13 |
DIZZINESS |
127 |
| 14 |
BRADYCARDIA |
121 |
| 15 |
AGITATION |
118 |
| 16 |
CONDITION AGGRAVATED |
114 |
| 17 |
VOMITING |
109 |
| 18 |
WEIGHT INCREASED |
103 |
| 19 |
IRRITABILITY |
102 |
| 20 |
PRODUCT SUBSTITUTION ISSUE |
102 |
| 21 |
DIARRHOEA |
96 |
| 22 |
ABNORMAL BEHAVIOUR |
92 |
| 23 |
DEPRESSION |
89 |
| 24 |
TREATMENT FAILURE |
89 |
| 25 |
PRODUCT DOSE OMISSION ISSUE |
88 |
| 26 |
PRODUCT USE IN UNAPPROVED INDICATION |
88 |
| 27 |
DECREASED APPETITE |
84 |
| 28 |
SEIZURE |
84 |
| 29 |
OVERDOSE |
83 |
| 30 |
HYPERTENSION |
82 |
| 31 |
SUICIDAL IDEATION |
82 |
| 32 |
RASH |
76 |
| 33 |
ANGER |
73 |
| 34 |
CONSTIPATION |
69 |
| 35 |
PRODUCT USE ISSUE |
67 |
| 36 |
ELECTROCARDIOGRAM QT PROLONGED |
66 |
| 37 |
PSYCHOMOTOR HYPERACTIVITY |
65 |
| 38 |
COMPLETED SUICIDE |
64 |
| 39 |
TACHYCARDIA |
63 |
| 40 |
FALL |
61 |
| 41 |
LETHARGY |
61 |
| 42 |
PRODUCT QUALITY ISSUE |
61 |
| 43 |
ABDOMINAL PAIN UPPER |
60 |
| 44 |
SEROTONIN SYNDROME |
58 |
| 45 |
SUICIDE ATTEMPT |
55 |
| 46 |
WEIGHT DECREASED |
54 |
| 47 |
SEDATION |
52 |
| 48 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
52 |
| 49 |
FEELING ABNORMAL |
51 |
| 50 |
HYPERHIDROSIS |
51 |
| 51 |
ASTHENIA |
50 |
| 52 |
MALAISE |
50 |
| 53 |
PAIN |
50 |
| 54 |
PRURITUS |
50 |
| 55 |
DISTURBANCE IN ATTENTION |
49 |
| 56 |
SINUS BRADYCARDIA |
49 |
| 57 |
TREMOR |
48 |
| 58 |
NO ADVERSE EVENT |
46 |
| 59 |
INTENTIONAL SELF-INJURY |
44 |
| 60 |
COMA |
43 |
| 61 |
PNEUMONIA |
43 |
| 62 |
COUGH |
42 |
| 63 |
DRUG DOSE OMISSION BY DEVICE |
42 |
| 64 |
ABDOMINAL PAIN |
41 |
| 65 |
DYSPNOEA |
41 |
| 66 |
DYSTONIA |
41 |
| 67 |
HALLUCINATION |
41 |
| 68 |
LOSS OF CONSCIOUSNESS |
39 |
| 69 |
PARAESTHESIA |
39 |
| 70 |
TIC |
39 |
| 71 |
BLOOD PRESSURE INCREASED |
38 |
| 72 |
EMOTIONAL DISORDER |
38 |
| 73 |
PYREXIA |
38 |
| 74 |
ARTHRALGIA |
37 |
| 75 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
37 |
| 76 |
HYPERSENSITIVITY |
37 |
| 77 |
SLEEP DISORDER |
37 |
| 78 |
CARDIAC ARREST |
35 |
| 79 |
DEATH |
34 |
| 80 |
INCORRECT DOSE ADMINISTERED |
34 |
| 81 |
DRY MOUTH |
33 |
| 82 |
IMPULSIVE BEHAVIOUR |
33 |
| 83 |
MOOD SWINGS |
33 |
| 84 |
PAIN IN EXTREMITY |
33 |
| 85 |
ABDOMINAL DISCOMFORT |
32 |
| 86 |
BEHAVIOUR DISORDER |
32 |
| 87 |
DYSARTHRIA |
32 |
| 88 |
EMOTIONAL DISTRESS |
32 |
| 89 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
32 |
| 90 |
PERIPHERAL SWELLING |
32 |
| 91 |
WITHDRAWAL SYNDROME |
32 |
| 92 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
31 |
| 93 |
HOSPITALISATION |
31 |
| 94 |
CONFUSIONAL STATE |
30 |
| 95 |
HEART RATE INCREASED |
30 |
| 96 |
MIGRAINE |
30 |
| 97 |
NASOPHARYNGITIS |
30 |
| 98 |
CHEST PAIN |
29 |
| 99 |
RESTLESSNESS |
29 |
| 100 |
BLOOD GLUCOSE INCREASED |
28 |
| 101 |
INJECTION SITE PAIN |
28 |
| 102 |
MUSCLE SPASMS |
28 |
| 103 |
RENAL FAILURE |
28 |
| 104 |
CHRONIC KIDNEY DISEASE |
27 |
| 105 |
DEVICE ISSUE |
27 |
| 106 |
MANIA |
27 |
| 107 |
PALPITATIONS |
27 |
| 108 |
PULMONARY OEDEMA |
27 |
| 109 |
ACUTE KIDNEY INJURY |
26 |
| 110 |
ASTHMA |
26 |
| 111 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
26 |
| 112 |
COVID-19 |
26 |
| 113 |
DEHYDRATION |
26 |
| 114 |
DRUG INTOLERANCE |
26 |
| 115 |
GAIT DISTURBANCE |
26 |
| 116 |
GYNAECOMASTIA |
26 |
| 117 |
PRODUCT DOSE OMISSION |
26 |
| 118 |
SYNCOPE |
26 |
| 119 |
COGNITIVE DISORDER |
25 |
| 120 |
DEVICE BREAKAGE |
25 |
| 121 |
ORTHOSTATIC HYPOTENSION |
25 |
| 122 |
TREATMENT NONCOMPLIANCE |
25 |
| 123 |
URTICARIA |
25 |
| 124 |
BACK PAIN |
24 |
| 125 |
DEPRESSED MOOD |
24 |
| 126 |
DISCOMFORT |
24 |
| 127 |
THERAPY NON-RESPONDER |
24 |
| 128 |
ADVERSE DRUG REACTION |
23 |
| 129 |
BRADYPNOEA |
23 |
| 130 |
ILLNESS |
23 |
| 131 |
INFLUENZA |
23 |
| 132 |
URINARY TRACT INFECTION |
23 |
| 133 |
VISION BLURRED |
23 |
| 134 |
CHOROIDAL EFFUSION |
22 |
| 135 |
DRUG DOSE OMISSION |
22 |
| 136 |
DYSKINESIA |
22 |
| 137 |
FLUSHING |
22 |
| 138 |
GASTROINTESTINAL HAEMORRHAGE |
22 |
| 139 |
NEUROLEPTIC MALIGNANT SYNDROME |
22 |
| 140 |
RESPIRATORY DEPRESSION |
22 |
| 141 |
THERAPY CESSATION |
22 |
| 142 |
AFFECTIVE DISORDER |
21 |
| 143 |
ATTENTION DEFICIT/HYPERACTIVITY DISORDER |
21 |
| 144 |
DEVICE LEAKAGE |
21 |
| 145 |
DEVICE MECHANICAL ISSUE |
21 |
| 146 |
ERYTHEMA |
21 |
| 147 |
MENTAL DISORDER |
21 |
| 148 |
BLOOD PRESSURE DECREASED |
20 |
| 149 |
CRYING |
20 |
| 150 |
GASTROINTESTINAL DISORDER |
20 |
| 151 |
GENERALISED TONIC-CLONIC SEIZURE |
20 |
| 152 |
INCREASED APPETITE |
20 |
| 153 |
MOOD ALTERED |
20 |
| 154 |
OEDEMA PERIPHERAL |
20 |
| 155 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
20 |
| 156 |
ACCIDENTAL OVERDOSE |
19 |
| 157 |
CATATONIA |
19 |
| 158 |
HALLUCINATION, AUDITORY |
19 |
| 159 |
NEPHROGENIC DIABETES INSIPIDUS |
19 |
| 160 |
PRODUCT ADHESION ISSUE |
19 |
| 161 |
ADVERSE EVENT |
18 |
| 162 |
DELIRIUM |
18 |
| 163 |
DISTRIBUTIVE SHOCK |
18 |
| 164 |
HYPERSOMNIA |
18 |
| 165 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
18 |
| 166 |
MACULAR DETACHMENT |
18 |
| 167 |
PRESYNCOPE |
18 |
| 168 |
PRODUCT PHYSICAL ISSUE |
18 |
| 169 |
SINUSITIS |
18 |
| 170 |
THERAPEUTIC RESPONSE DECREASED |
18 |
| 171 |
URINARY RETENTION |
18 |
| 172 |
AFFECT LABILITY |
17 |
| 173 |
AMNESIA |
17 |
| 174 |
DERMATITIS ATOPIC |
17 |
| 175 |
DRUG EFFECT DECREASED |
17 |
| 176 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
17 |
| 177 |
INTENTIONAL DOSE OMISSION |
17 |
| 178 |
INTENTIONAL PRODUCT USE ISSUE |
17 |
| 179 |
MEMORY IMPAIRMENT |
17 |
| 180 |
NIGHTMARE |
17 |
| 181 |
UNDERDOSE |
17 |
| 182 |
CEREBRAL DISORDER |
16 |
| 183 |
CHILLS |
16 |
| 184 |
CONTUSION |
16 |
| 185 |
DRUG WITHDRAWAL SYNDROME |
16 |
| 186 |
HEART RATE DECREASED |
16 |
| 187 |
INFECTION |
16 |
| 188 |
INTENTIONAL PRODUCT MISUSE |
16 |
| 189 |
LACTIC ACIDOSIS |
16 |
| 190 |
OBSESSIVE-COMPULSIVE DISORDER |
16 |
| 191 |
PRODUCT ADMINISTRATION INTERRUPTED |
16 |
| 192 |
SELF-DESTRUCTIVE BEHAVIOUR |
16 |
| 193 |
SINUS TACHYCARDIA |
16 |
| 194 |
STRESS CARDIOMYOPATHY |
16 |
| 195 |
THERAPY CHANGE |
16 |
| 196 |
ABDOMINAL DISTENSION |
15 |
| 197 |
DRUG LEVEL INCREASED |
15 |
| 198 |
PRODUCT AVAILABILITY ISSUE |
15 |
| 199 |
PSYCHOTIC DISORDER |
15 |
| 200 |
RECALLED PRODUCT ADMINISTERED |
15 |
| 201 |
STRESS |
15 |
| 202 |
UNEVALUABLE EVENT |
15 |
| 203 |
ACCIDENTAL EXPOSURE TO PRODUCT |
14 |
| 204 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
14 |
| 205 |
BLINDNESS UNILATERAL |
14 |
| 206 |
CARDIAC FAILURE |
14 |
| 207 |
DEVICE USE ERROR |
14 |
| 208 |
DRUG HYPERSENSITIVITY |
14 |
| 209 |
GASTROOESOPHAGEAL REFLUX DISEASE |
14 |
| 210 |
IMPAIRED QUALITY OF LIFE |
14 |
| 211 |
MUSCULAR WEAKNESS |
14 |
| 212 |
NEPHROGENIC ANAEMIA |
14 |
| 213 |
NEPHROLITHIASIS |
14 |
| 214 |
PRIAPISM |
14 |
| 215 |
RHINORRHOEA |
14 |
| 216 |
SINUS ARREST |
14 |
| 217 |
SURGERY |
14 |
| 218 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
14 |
| 219 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
14 |
| 220 |
AKATHISIA |
13 |
| 221 |
ANAEMIA |
13 |
| 222 |
DIABETIC KETOACIDOSIS |
13 |
| 223 |
DYSPEPSIA |
13 |
| 224 |
DYSPHAGIA |
13 |
| 225 |
EDUCATIONAL PROBLEM |
13 |
| 226 |
ENCEPHALOPATHY |
13 |
| 227 |
HALLUCINATION, VISUAL |
13 |
| 228 |
MENTAL STATUS CHANGES |
13 |
| 229 |
MYDRIASIS |
13 |
| 230 |
NERVOUS SYSTEM DISORDER |
13 |
| 231 |
PARANOIA |
13 |
| 232 |
REBOUND EFFECT |
13 |
| 233 |
SEDATION COMPLICATION |
13 |
| 234 |
SPEECH DISORDER |
13 |
| 235 |
SWELLING |
13 |
| 236 |
SWELLING FACE |
13 |
| 237 |
THERAPEUTIC RESPONSE UNEXPECTED |
13 |
| 238 |
URINARY INCONTINENCE |
13 |
| 239 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
13 |
| 240 |
APPLICATION SITE ERYTHEMA |
12 |
| 241 |
DISTRACTIBILITY |
12 |
| 242 |
DRY SKIN |
12 |
| 243 |
EAR INFECTION |
12 |
| 244 |
END STAGE RENAL DISEASE |
12 |
| 245 |
FEELING HOT |
12 |
| 246 |
HYPOXIA |
12 |
| 247 |
MENTAL IMPAIRMENT |
12 |
| 248 |
MOVEMENT DISORDER |
12 |
| 249 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
12 |
| 250 |
MUSCLE RIGIDITY |
12 |
| 251 |
NASAL CONGESTION |
12 |
| 252 |
OBESITY |
12 |
| 253 |
OROPHARYNGEAL PAIN |
12 |
| 254 |
PRESCRIBED OVERDOSE |
12 |
| 255 |
PRODUCT DISPENSING ERROR |
12 |
| 256 |
PSORIASIS |
12 |
| 257 |
RESPIRATORY FAILURE |
12 |
| 258 |
THINKING ABNORMAL |
12 |
| 259 |
VISUAL IMPAIRMENT |
12 |
| 260 |
ALOPECIA |
11 |
| 261 |
ANTICHOLINERGIC SYNDROME |
11 |
| 262 |
APATHY |
11 |
| 263 |
ARRHYTHMIA |
11 |
| 264 |
BALANCE DISORDER |
11 |
| 265 |
BLOOD TRIGLYCERIDES INCREASED |
11 |
| 266 |
DEFIANT BEHAVIOUR |
11 |
| 267 |
DEVICE DIFFICULT TO USE |
11 |
| 268 |
DIPLOPIA |
11 |
| 269 |
ECZEMA |
11 |
| 270 |
ENURESIS |
11 |
| 271 |
GENERAL PHYSICAL HEALTH DETERIORATION |
11 |
| 272 |
HYPERTENSIVE URGENCY |
11 |
| 273 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
11 |
| 274 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
11 |
| 275 |
PALLOR |
11 |
| 276 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
11 |
| 277 |
RETCHING |
11 |
| 278 |
SCREAMING |
11 |
| 279 |
SELF-INJURIOUS IDEATION |
11 |
| 280 |
SUSPECTED SUICIDE |
11 |
| 281 |
THERAPY PARTIAL RESPONDER |
11 |
| 282 |
UNRESPONSIVE TO STIMULI |
11 |
| 283 |
VERTIGO |
11 |
| 284 |
ACNE |
10 |
| 285 |
APPLICATION SITE PRURITUS |
10 |
| 286 |
BIPOLAR DISORDER |
10 |
| 287 |
BRAIN FOG |
10 |
| 288 |
CARDIAC DISORDER |
10 |
| 289 |
CARDIAC FAILURE ACUTE |
10 |
| 290 |
DISORIENTATION |
10 |
| 291 |
DRUG TOLERANCE |
10 |
| 292 |
EYE IRRITATION |
10 |
| 293 |
FLATULENCE |
10 |
| 294 |
FRUSTRATION TOLERANCE DECREASED |
10 |
| 295 |
GASTROENTERITIS VIRAL |
10 |
| 296 |
HYPOAESTHESIA |
10 |
| 297 |
INABILITY TO AFFORD MEDICATION |
10 |
| 298 |
INJECTION SITE REACTION |
10 |
| 299 |
MIDDLE INSOMNIA |
10 |
| 300 |
MYOCARDIAL INFARCTION |
10 |
| 301 |
OEDEMA |
10 |
| 302 |
POOR QUALITY DEVICE USED |
10 |
| 303 |
POOR QUALITY SLEEP |
10 |
| 304 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
10 |
| 305 |
PRODUCT ADMINISTRATION ERROR |
10 |
| 306 |
PULSELESS ELECTRICAL ACTIVITY |
10 |
| 307 |
RENAL IMPAIRMENT |
10 |
| 308 |
SALIVARY HYPERSECRETION |
10 |
| 309 |
SEROUS RETINAL DETACHMENT |
10 |
| 310 |
SKIN EXFOLIATION |
10 |
| 311 |
THERAPEUTIC RESPONSE SHORTENED |
10 |
| 312 |
THERAPY INTERRUPTED |
10 |
| 313 |
VASOPLEGIA SYNDROME |
10 |
| 314 |
ALTERED STATE OF CONSCIOUSNESS |
9 |
| 315 |
BRONCHITIS |
9 |
| 316 |
BRUGADA SYNDROME |
9 |
| 317 |
CROHN^S DISEASE |
9 |
| 318 |
DELUSION |
9 |
| 319 |
DISSOCIATION |
9 |
| 320 |
DROOLING |
9 |
| 321 |
DRUG DEPENDENCE |
9 |
| 322 |
DRUG PRESCRIBING ERROR |
9 |
| 323 |
DYSPHEMIA |
9 |
| 324 |
EATING DISORDER |
9 |
| 325 |
EOSINOPHILIC OESOPHAGITIS |
9 |
| 326 |
EPISTAXIS |
9 |
| 327 |
EXTRA DOSE ADMINISTERED |
9 |
| 328 |
FLUID RETENTION |
9 |
| 329 |
HEPATIC ENZYME INCREASED |
9 |
| 330 |
HYPERGLYCAEMIA |
9 |
| 331 |
HYPOPROTEINAEMIA |
9 |
| 332 |
IMMUNE THROMBOCYTOPENIC PURPURA |
9 |
| 333 |
IMPAIRED GASTRIC EMPTYING |
9 |
| 334 |
INSULIN RESISTANCE |
9 |
| 335 |
INSURANCE ISSUE |
9 |
| 336 |
MOBILITY DECREASED |
9 |
| 337 |
NERVOUSNESS |
9 |
| 338 |
NEUROPATHY PERIPHERAL |
9 |
| 339 |
OPPOSITIONAL DEFIANT DISORDER |
9 |
| 340 |
PANIC ATTACK |
9 |
| 341 |
PRE-EXISTING CONDITION IMPROVED |
9 |
| 342 |
PRODUCT PREPARATION ISSUE |
9 |
| 343 |
PRODUCT TASTE ABNORMAL |
9 |
| 344 |
PRODUCT USE COMPLAINT |
9 |
| 345 |
RASH PRURITIC |
9 |
| 346 |
RENAL INJURY |
9 |
| 347 |
SHOCK |
9 |
| 348 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
9 |
| 349 |
STATUS EPILEPTICUS |
9 |
| 350 |
SUBRETINAL FLUID |
9 |
| 351 |
TARDIVE DYSKINESIA |
9 |
| 352 |
THERAPEUTIC RESPONSE CHANGED |
9 |
| 353 |
VIRAL INFECTION |
9 |
| 354 |
ARTHRITIS |
8 |
| 355 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
8 |
| 356 |
BRAIN OEDEMA |
8 |
| 357 |
CATARACT |
8 |
| 358 |
CEREBROVASCULAR ACCIDENT |
8 |
| 359 |
DEVICE MALFUNCTION |
8 |
| 360 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
8 |
| 361 |
DRUG EFFECT INCOMPLETE |
8 |
| 362 |
DRUG LEVEL ABOVE THERAPEUTIC |
8 |
| 363 |
DYSPHONIA |
8 |
| 364 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
8 |
| 365 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
8 |
| 366 |
EXTRAPYRAMIDAL DISORDER |
8 |
| 367 |
FEAR |
8 |
| 368 |
FEELING JITTERY |
8 |
| 369 |
GAIT INABILITY |
8 |
| 370 |
HOMICIDAL IDEATION |
8 |
| 371 |
HYPOPHAGIA |
8 |
| 372 |
LEUKOCYTOSIS |
8 |
| 373 |
LOGORRHOEA |
8 |
| 374 |
MEDICATION RESIDUE PRESENT |
8 |
| 375 |
MUSCLE TWITCHING |
8 |
| 376 |
MYALGIA |
8 |
| 377 |
NIGHT SWEATS |
8 |
| 378 |
OROMANDIBULAR DYSTONIA |
8 |
| 379 |
PRODUCT DOSE OMISSION IN ERROR |
8 |
| 380 |
RENAL DISORDER |
8 |
| 381 |
RESPIRATORY ARREST |
8 |
| 382 |
RIB FRACTURE |
8 |
| 383 |
SENSORY DISTURBANCE |
8 |
| 384 |
THIRST |
8 |
| 385 |
TOURETTE^S DISORDER |
8 |
| 386 |
UPPER AIRWAY OBSTRUCTION |
8 |
| 387 |
ABNORMAL WEIGHT GAIN |
7 |
| 388 |
ANHEDONIA |
7 |
| 389 |
APPLICATION SITE IRRITATION |
7 |
| 390 |
ASPIRATION |
7 |
| 391 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
7 |
| 392 |
AUTISM SPECTRUM DISORDER |
7 |
| 393 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
7 |
| 394 |
BLISTER |
7 |
| 395 |
BRUXISM |
7 |
| 396 |
CARDIOGENIC SHOCK |
7 |
| 397 |
CARDIOTOXICITY |
7 |
| 398 |
DEVICE DELIVERY SYSTEM ISSUE |
7 |
| 399 |
DISEASE PROGRESSION |
7 |
| 400 |
DISTURBANCE IN SOCIAL BEHAVIOUR |
7 |
| 401 |
DRUG EFFECT LESS THAN EXPECTED |
7 |
| 402 |
DYSGEUSIA |
7 |
| 403 |
FUNGAL INFECTION |
7 |
| 404 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
7 |
| 405 |
HEAD INJURY |
7 |
| 406 |
HORNER^S SYNDROME |
7 |
| 407 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
7 |
| 408 |
INJECTION SITE ERYTHEMA |
7 |
| 409 |
INJECTION SITE PRURITUS |
7 |
| 410 |
INJECTION SITE SWELLING |
7 |
| 411 |
MEDICATION ERROR |
7 |
| 412 |
MIOSIS |
7 |
| 413 |
NEUROTOXICITY |
7 |
| 414 |
PARALYSIS |
7 |
| 415 |
PARKINSONISM |
7 |
| 416 |
PARKINSON^S DISEASE |
7 |
| 417 |
PLEURAL EFFUSION |
7 |
| 418 |
POLLAKIURIA |
7 |
| 419 |
POST-TRAUMATIC STRESS DISORDER |
7 |
| 420 |
PRODUCT PRESCRIBING ISSUE |
7 |
| 421 |
PULMONARY EMBOLISM |
7 |
| 422 |
RASH ERYTHEMATOUS |
7 |
| 423 |
SEXUAL DYSFUNCTION |
7 |
| 424 |
TACHYPHRENIA |
7 |
| 425 |
ALANINE AMINOTRANSFERASE INCREASED |
6 |
| 426 |
ANION GAP |
6 |
| 427 |
APHASIA |
6 |
| 428 |
BLOOD GLUCOSE DECREASED |
6 |
| 429 |
BUNDLE BRANCH BLOCK RIGHT |
6 |
| 430 |
CARDIAC DYSFUNCTION |
6 |
| 431 |
CARDIO-RESPIRATORY ARREST |
6 |
| 432 |
CHEST DISCOMFORT |
6 |
| 433 |
CHOROIDAL DETACHMENT |
6 |
| 434 |
CIRCULATORY COLLAPSE |
6 |
| 435 |
CYSTIC FIBROSIS |
6 |
| 436 |
DERMATILLOMANIA |
6 |
| 437 |
DERMATITIS CONTACT |
6 |
| 438 |
DEVICE INFORMATION OUTPUT ISSUE |
6 |
| 439 |
DEVICE PHYSICAL PROPERTY ISSUE |
6 |
| 440 |
DISEASE RECURRENCE |
6 |
| 441 |
DIZZINESS POSTURAL |
6 |
| 442 |
DRUG ABUSE |
6 |
| 443 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
6 |
| 444 |
EUPHORIC MOOD |
6 |
| 445 |
EYE SWELLING |
6 |
| 446 |
GLOMERULAR FILTRATION RATE DECREASED |
6 |
| 447 |
GRANDIOSITY |
6 |
| 448 |
HYPERAMMONAEMIA |
6 |
| 449 |
HYPERPHAGIA |
6 |
| 450 |
HYPERTENSIVE EMERGENCY |
6 |
| 451 |
HYPOTHERMIA |
6 |
| 452 |
ILL-DEFINED DISORDER |
6 |
| 453 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
6 |
| 454 |
INHIBITORY DRUG INTERACTION |
6 |
| 455 |
INITIAL INSOMNIA |
6 |
| 456 |
INJURY |
6 |
| 457 |
JOINT SWELLING |
6 |
| 458 |
LIQUID PRODUCT PHYSICAL ISSUE |
6 |
| 459 |
PAIN OF SKIN |
6 |
| 460 |
PRODUCT COMPLAINT |
6 |
| 461 |
PRODUCT STORAGE ERROR |
6 |
| 462 |
RESTLESS LEGS SYNDROME |
6 |
| 463 |
SKIN BURNING SENSATION |
6 |
| 464 |
SKIN DISCOLOURATION |
6 |
| 465 |
SLEEP TERROR |
6 |
| 466 |
SOMNAMBULISM |
6 |
| 467 |
TINNITUS |
6 |
| 468 |
WHITE BLOOD CELL COUNT INCREASED |
6 |
| 469 |
ACTIVATION SYNDROME |
5 |
| 470 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
5 |
| 471 |
ANAPHYLACTIC SHOCK |
5 |
| 472 |
APNOEA |
5 |
| 473 |
APPLICATION SITE PAIN |
5 |
| 474 |
ASPARTATE AMINOTRANSFERASE INCREASED |
5 |
| 475 |
ATRIOVENTRICULAR BLOCK COMPLETE |
5 |
| 476 |
BLOOD CHOLESTEROL INCREASED |
5 |
| 477 |
BLOOD POTASSIUM DECREASED |
5 |
| 478 |
BLOOD UREA INCREASED |
5 |
| 479 |
BLOOD URIC ACID INCREASED |
5 |
| 480 |
BURNING SENSATION |
5 |
| 481 |
CARDIAC ANEURYSM |
5 |
| 482 |
CLOSTRIDIUM DIFFICILE INFECTION |
5 |
| 483 |
CYSTITIS |
5 |
| 484 |
DEVICE ADHESION ISSUE |
5 |
| 485 |
DEVICE DEFECTIVE |
5 |
| 486 |
DRUG-GENETIC INTERACTION |
5 |
| 487 |
DRY EYE |
5 |
| 488 |
DYSPHORIA |
5 |
| 489 |
DYSURIA |
5 |
| 490 |
ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL |
5 |
| 491 |
EXCESSIVE EYE BLINKING |
5 |
| 492 |
EYE DISORDER |
5 |
| 493 |
EYE PAIN |
5 |
| 494 |
EYE PRURITUS |
5 |
| 495 |
FORMICATION |
5 |
| 496 |
GRANULOCYTOPENIA |
5 |
| 497 |
GRIMACING |
5 |
| 498 |
HAEMORRHAGE |
5 |
| 499 |
HAIR GROWTH ABNORMAL |
5 |
| 500 |
HERPES ZOSTER |
5 |
| 501 |
HOSTILITY |
5 |
| 502 |
HOT FLUSH |
5 |
| 503 |
HUNGER |
5 |
| 504 |
HYPERTONIC BLADDER |
5 |
| 505 |
HYPOGLYCAEMIA |
5 |
| 506 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
5 |
| 507 |
IMPULSE-CONTROL DISORDER |
5 |
| 508 |
INCORRECT DRUG ADMINISTRATION DURATION |
5 |
| 509 |
INFLAMMATION |
5 |
| 510 |
INJECTION SITE MASS |
5 |
| 511 |
LEFT VENTRICULAR HYPERTROPHY |
5 |
| 512 |
LIMB DISCOMFORT |
5 |
| 513 |
LIVER FUNCTION TEST ABNORMAL |
5 |
| 514 |
LOWER LIMB FRACTURE |
5 |
| 515 |
MUSCULOSKELETAL STIFFNESS |
5 |
| 516 |
NECK PAIN |
5 |
| 517 |
NEURALGIA |
5 |
| 518 |
OCULAR HYPERAEMIA |
5 |
| 519 |
ORAL PAIN |
5 |
| 520 |
PETIT MAL EPILEPSY |
5 |
| 521 |
PHYSICAL ASSAULT |
5 |
| 522 |
PLATELET COUNT DECREASED |
5 |
| 523 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
5 |
| 524 |
PRESCRIBED UNDERDOSE |
5 |
| 525 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
5 |
| 526 |
PROCEDURAL PAIN |
5 |
| 527 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
5 |
| 528 |
PRODUCT FORMULATION ISSUE |
5 |
| 529 |
REBOUND ACID HYPERSECRETION |
5 |
| 530 |
RECTAL HAEMORRHAGE |
5 |
| 531 |
RESPIRATORY ACIDOSIS |
5 |
| 532 |
RESTLESS LEG AUGMENTATION SYNDROME |
5 |
| 533 |
RHABDOMYOLYSIS |
5 |
| 534 |
RHINOVIRUS INFECTION |
5 |
| 535 |
SCAR |
5 |
| 536 |
SEPSIS |
5 |
| 537 |
SLEEP APNOEA SYNDROME |
5 |
| 538 |
SLEEP DEFICIT |
5 |
| 539 |
SLUGGISHNESS |
5 |
| 540 |
STARING |
5 |
| 541 |
STOMATITIS |
5 |
| 542 |
SUICIDAL BEHAVIOUR |
5 |
| 543 |
TEMPERATURE INTOLERANCE |
5 |
| 544 |
THERAPEUTIC PRODUCT INEFFECTIVE |
5 |
| 545 |
TRANSPLANT REJECTION |
5 |
| 546 |
TRICHOTILLOMANIA |
5 |
| 547 |
TRISMUS |
5 |
| 548 |
UPPER RESPIRATORY TRACT INFECTION |
5 |
| 549 |
VENTRICULAR FIBRILLATION |
5 |
| 550 |
VENTRICULAR TACHYCARDIA |
5 |
| 551 |
WHITE BLOOD CELL COUNT DECREASED |
5 |
| 552 |
ABNORMAL DREAMS |
4 |
| 553 |
ABNORMAL LOSS OF WEIGHT |
4 |
| 554 |
ANAL INCONTINENCE |
4 |
| 555 |
ANAPHYLACTIC REACTION |
4 |
| 556 |
ANTICHOLINERGIC EFFECT |
4 |
| 557 |
APPLICATION SITE RASH |
4 |
| 558 |
AREFLEXIA |
4 |
| 559 |
ARTHROPOD BITE |
4 |
| 560 |
ATAXIA |
4 |
| 561 |
ATRIOVENTRICULAR BLOCK |
4 |
| 562 |
ATRIOVENTRICULAR DISSOCIATION |
4 |
| 563 |
BLEPHAROSPASM |
4 |
| 564 |
BLINDNESS |
4 |
| 565 |
BLOOD LACTIC ACID INCREASED |
4 |
| 566 |
BLOOD PROLACTIN INCREASED |
4 |
| 567 |
BLOOD SODIUM DECREASED |
4 |
| 568 |
BODY MASS INDEX DECREASED |
4 |
| 569 |
BRAIN INJURY |
4 |
| 570 |
CARPAL TUNNEL SYNDROME |
4 |
| 571 |
CELLULITIS |
4 |
| 572 |
COLD SWEAT |
4 |
| 573 |
COORDINATION ABNORMAL |
4 |
| 574 |
CRANIOCEREBRAL INJURY |
4 |
| 575 |
CYANOSIS |
4 |
| 576 |
DARK CIRCLES UNDER EYES |
4 |
| 577 |
DEAFNESS |
4 |
| 578 |
DECREASED ACTIVITY |
4 |
| 579 |
DEEP VEIN THROMBOSIS |
4 |
| 580 |
DISINHIBITION |
4 |
| 581 |
DISRUPTIVE MOOD DYSREGULATION DISORDER |
4 |
| 582 |
DRUG RESISTANCE |
4 |
| 583 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
4 |
| 584 |
DYSSTASIA |
4 |
| 585 |
ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED |
4 |
| 586 |
ELECTROCARDIOGRAM T WAVE PEAKED |
4 |
| 587 |
EXPIRED DEVICE USED |
4 |
| 588 |
EXPIRED PRODUCT ADMINISTERED |
4 |
| 589 |
EXPOSURE DURING PREGNANCY |
4 |
| 590 |
FEELING COLD |
4 |
| 591 |
GASTRITIS |
4 |
| 592 |
GOUT |
4 |
| 593 |
HAEMATOCHEZIA |
4 |
| 594 |
HAEMOGLOBIN DECREASED |
4 |
| 595 |
HAEMORRHOIDAL HAEMORRHAGE |
4 |
| 596 |
HEPATIC FAILURE |
4 |
| 597 |
HEPATITIS ACUTE |
4 |
| 598 |
HYPERTENSIVE CRISIS |
4 |
| 599 |
HYPOMANIA |
4 |
| 600 |
HYPORESPONSIVE TO STIMULI |
4 |
| 601 |
IMPAIRED WORK ABILITY |
4 |
| 602 |
INCONTINENCE |
4 |
| 603 |
INFLUENZA LIKE ILLNESS |
4 |
| 604 |
INFUSION SITE ERYTHEMA |
4 |
| 605 |
INJECTION SITE HAEMORRHAGE |
4 |
| 606 |
INJECTION SITE URTICARIA |
4 |
| 607 |
INTESTINAL OBSTRUCTION |
4 |
| 608 |
JOINT INJURY |
4 |
| 609 |
JOINT STIFFNESS |
4 |
| 610 |
LIBIDO DECREASED |
4 |
| 611 |
LIP SWELLING |
4 |
| 612 |
LOCALISED INFECTION |
4 |
| 613 |
LOSS OF LIBIDO |
4 |
| 614 |
LUNG DISORDER |
4 |
| 615 |
MAJOR DEPRESSION |
4 |
| 616 |
MAST CELL ACTIVATION SYNDROME |
4 |
| 617 |
MENSTRUAL DISORDER |
4 |
| 618 |
METABOLIC ACIDOSIS |
4 |
| 619 |
MOUTH ULCERATION |
4 |
| 620 |
NEEDLE ISSUE |
4 |
| 621 |
NEGATIVISM |
4 |
| 622 |
NEUTROPENIA |
4 |
| 623 |
OSTEOARTHRITIS |
4 |
| 624 |
OVERWEIGHT |
4 |
| 625 |
OXYGEN SATURATION DECREASED |
4 |
| 626 |
PERIODIC LIMB MOVEMENT DISORDER |
4 |
| 627 |
PHARYNGITIS STREPTOCOCCAL |
4 |
| 628 |
PNEUMONIA ASPIRATION |
4 |
| 629 |
PNEUMOTHORAX |
4 |
| 630 |
POISONING DELIBERATE |
4 |
| 631 |
POOR VENOUS ACCESS |
4 |
| 632 |
PRODUCT DISPENSING ISSUE |
4 |
| 633 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
4 |
| 634 |
PRODUCT PRESCRIBING ERROR |
4 |
| 635 |
PULMONARY HAEMORRHAGE |
4 |
| 636 |
RASH MACULAR |
4 |
| 637 |
RASH PAPULAR |
4 |
| 638 |
RENAL CELL CARCINOMA |
4 |
| 639 |
RENAL TUBULAR NECROSIS |
4 |
| 640 |
SCOLIOSIS |
4 |
| 641 |
SEPTIC SHOCK |
4 |
| 642 |
SICKLE CELL ANAEMIA WITH CRISIS |
4 |
| 643 |
SKIN IRRITATION |
4 |
| 644 |
SOCIAL ANXIETY DISORDER |
4 |
| 645 |
SOCIAL PROBLEM |
4 |
| 646 |
SPINAL OPERATION |
4 |
| 647 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
| 648 |
STREPTOCOCCAL INFECTION |
4 |
| 649 |
SUPRAVENTRICULAR EXTRASYSTOLES |
4 |
| 650 |
TEARFULNESS |
4 |
| 651 |
THROMBOCYTOPENIA |
4 |
| 652 |
TRANSAMINASES INCREASED |
4 |
| 653 |
TROPONIN I INCREASED |
4 |
| 654 |
UPPER LIMB FRACTURE |
4 |
| 655 |
WHEEZING |
4 |
| 656 |
ABASIA |
3 |
| 657 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
3 |
| 658 |
ACUTE RESPIRATORY FAILURE |
3 |
| 659 |
ADHESIVE TAPE USE |
3 |
| 660 |
AGEUSIA |
3 |
| 661 |
AMENORRHOEA |
3 |
| 662 |
ANGIOEDEMA |
3 |
| 663 |
ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC |
3 |
| 664 |
APPETITE DISORDER |
3 |
| 665 |
ARTERIOSPASM CORONARY |
3 |
| 666 |
ARTHROPATHY |
3 |
| 667 |
ATRIAL FIBRILLATION |
3 |
| 668 |
BACK DISORDER |
3 |
| 669 |
BENIGN PROSTATIC HYPERPLASIA |
3 |
| 670 |
BEZOAR |
3 |
| 671 |
BLOOD ALBUMIN DECREASED |
3 |
| 672 |
BLOOD CREATININE DECREASED |
3 |
| 673 |
BLOOD POTASSIUM INCREASED |
3 |
| 674 |
BLOOD PROLACTIN DECREASED |
3 |
| 675 |
BLOOD TESTOSTERONE DECREASED |
3 |
| 676 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
3 |
| 677 |
CATHETER SITE INFECTION |
3 |
| 678 |
CHANGE IN SEIZURE PRESENTATION |
3 |
| 679 |
CHOKING |
3 |
| 680 |
CHORIORETINAL DISORDER |
3 |
| 681 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
3 |
| 682 |
CLONIC CONVULSION |
3 |
| 683 |
CONCUSSION |
3 |
| 684 |
CONTRAINDICATED PRODUCT PRESCRIBED |
3 |
| 685 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
3 |
| 686 |
DEMENTIA |
3 |
| 687 |
DEVICE DISLOCATION |
3 |
| 688 |
DEVICE MATERIAL ISSUE |
3 |
| 689 |
DISABILITY |
3 |
| 690 |
DRUG ADMINISTRATION ERROR |
3 |
| 691 |
DRUG DELIVERY SYSTEM ISSUE |
3 |
| 692 |
DRUG DISPENSING ERROR |
3 |
| 693 |
DRUG SCREEN FALSE POSITIVE |
3 |
| 694 |
DRUG TOLERANCE DECREASED |
3 |
| 695 |
DYSPNOEA EXERTIONAL |
3 |
| 696 |
EAR PAIN |
3 |
| 697 |
ELECTRIC SHOCK SENSATION |
3 |
| 698 |
ELECTROCARDIOGRAM QT SHORTENED |
3 |
| 699 |
ENDOCARDITIS |
3 |
| 700 |
ENERGY INCREASED |
3 |
| 701 |
ERECTILE DYSFUNCTION |
3 |
| 702 |
EXOSTOSIS |
3 |
| 703 |
EXPIRED DRUG ADMINISTERED |
3 |
| 704 |
EXPOSURE VIA INGESTION |
3 |
| 705 |
EXPOSURE VIA SKIN CONTACT |
3 |
| 706 |
EYE MOVEMENT DISORDER |
3 |
| 707 |
FEEDING DISORDER |
3 |
| 708 |
FIBROMYALGIA |
3 |
| 709 |
FLANK PAIN |
3 |
| 710 |
FOETAL EXPOSURE DURING PREGNANCY |
3 |
| 711 |
FOOD ALLERGY |
3 |
| 712 |
FOOT DEFORMITY |
3 |
| 713 |
FULL BLOOD COUNT DECREASED |
3 |
| 714 |
GASTRIC DISORDER |
3 |
| 715 |
GASTROINTESTINAL PAIN |
3 |
| 716 |
GLYCOGEN STORAGE DISEASE TYPE VIII |
3 |
| 717 |
GROWTH RETARDATION |
3 |
| 718 |
HAEMATEMESIS |
3 |
| 719 |
HEAD DISCOMFORT |
3 |
| 720 |
HEREDITARY ANGIOEDEMA |
3 |
| 721 |
HIRSUTISM |
3 |
| 722 |
HYPERPARATHYROIDISM SECONDARY |
3 |
| 723 |
HYPERPROLACTINAEMIA |
3 |
| 724 |
HYPERTRICHOSIS |
3 |
| 725 |
HYPERVENTILATION |
3 |
| 726 |
HYPONATRAEMIA |
3 |
| 727 |
HYPOTHYROIDISM |
3 |
| 728 |
HYSTERECTOMY |
3 |
| 729 |
IMPAIRED HEALING |
3 |
| 730 |
INCREASED TENDENCY TO BRUISE |
3 |
| 731 |
INFUSION SITE HAEMORRHAGE |
3 |
| 732 |
INFUSION SITE PAIN |
3 |
| 733 |
INFUSION SITE REACTION |
3 |
| 734 |
INJECTION SITE BRUISING |
3 |
| 735 |
INJECTION SITE RASH |
3 |
| 736 |
IRRITABLE BOWEL SYNDROME |
3 |
| 737 |
JOINT DISLOCATION |
3 |
| 738 |
LEARNING DISABILITY |
3 |
| 739 |
LEFT VENTRICULAR DYSFUNCTION |
3 |
| 740 |
LIMB INJURY |
3 |
| 741 |
LOW DENSITY LIPOPROTEIN INCREASED |
3 |
| 742 |
MALABSORPTION |
3 |
| 743 |
MATERNAL EXPOSURE DURING PREGNANCY |
3 |
| 744 |
MENINGITIS |
3 |
| 745 |
MENSTRUATION IRREGULAR |
3 |
| 746 |
MICROCYTIC ANAEMIA |
3 |
| 747 |
MUSCLE TIGHTNESS |
3 |
| 748 |
MUSCULOSKELETAL DISCOMFORT |
3 |
| 749 |
NEAR DEATH EXPERIENCE |
3 |
| 750 |
NONSPECIFIC REACTION |
3 |
| 751 |
OSTEOPENIA |
3 |
| 752 |
PAIN IN JAW |
3 |
| 753 |
PANCREATITIS |
3 |
| 754 |
PARADOXICAL DRUG REACTION |
3 |
| 755 |
PATIENT UNCOOPERATIVE |
3 |
| 756 |
PERIPHERAL COLDNESS |
3 |
| 757 |
PHYSICAL DISABILITY |
3 |
| 758 |
PITUITARY TUMOUR |
3 |
| 759 |
POLYCYSTIC OVARIAN SYNDROME |
3 |
| 760 |
POLYDIPSIA |
3 |
| 761 |
POST PROCEDURAL COMPLICATION |
3 |
| 762 |
PRODUCT COMMUNICATION ISSUE |
3 |
| 763 |
PRODUCT CONTAINER ISSUE |
3 |
| 764 |
PRODUCT CONTAMINATION |
3 |
| 765 |
PRODUCT DISTRIBUTION ISSUE |
3 |
| 766 |
PRODUCT PACKAGING QUANTITY ISSUE |
3 |
| 767 |
PRODUCT PREPARATION ERROR |
3 |
| 768 |
PRODUCT SUPPLY ISSUE |
3 |
| 769 |
PRODUCTIVE COUGH |
3 |
| 770 |
PROPOFOL INFUSION SYNDROME |
3 |
| 771 |
PRURITUS GENERALISED |
3 |
| 772 |
PSEUDOMONAS INFECTION |
3 |
| 773 |
PSORIATIC ARTHROPATHY |
3 |
| 774 |
PULMONARY CONGESTION |
3 |
| 775 |
PULMONARY FUNCTION TEST DECREASED |
3 |
| 776 |
PULSE ABSENT |
3 |
| 777 |
PYELOCALIECTASIS |
3 |
| 778 |
REACTION TO EXCIPIENT |
3 |
| 779 |
RESPIRATORY DISTRESS |
3 |
| 780 |
RESPIRATORY RATE DECREASED |
3 |
| 781 |
RESPIRATORY TRACT INFECTION |
3 |
| 782 |
SENSITIVE SKIN |
3 |
| 783 |
SINUS CONGESTION |
3 |
| 784 |
SINUS DISORDER |
3 |
| 785 |
SINUS OPERATION |
3 |
| 786 |
SKIN FISSURES |
3 |
| 787 |
SKIN LACERATION |
3 |
| 788 |
SLEEP TALKING |
3 |
| 789 |
SNORING |
3 |
| 790 |
STAPHYLOCOCCAL INFECTION |
3 |
| 791 |
SWEAT TEST ABNORMAL |
3 |
| 792 |
SWELLING OF EYELID |
3 |
| 793 |
SWOLLEN TONGUE |
3 |
| 794 |
SYMPTOM MASKED |
3 |
| 795 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
3 |
| 796 |
TRANSIENT ISCHAEMIC ATTACK |
3 |
| 797 |
TROPONIN INCREASED |
3 |
| 798 |
TYPE 2 DIABETES MELLITUS |
3 |
| 799 |
URINARY TRACT OBSTRUCTION |
3 |
| 800 |
VAGINAL HAEMORRHAGE |
3 |
| 801 |
VENTRICULAR DYSKINESIA |
3 |
| 802 |
VITAMIN D DECREASED |
3 |
| 803 |
WEIGHT FLUCTUATION |
3 |
| 804 |
WEIGHT GAIN POOR |
3 |
| 805 |
WRONG DOSE |
3 |
| 806 |
ABDOMINAL PAIN LOWER |
2 |
| 807 |
ABNORMAL UTERINE BLEEDING |
2 |
| 808 |
ACIDOSIS |
2 |
| 809 |
ACUTE MYELOID LEUKAEMIA |
2 |
| 810 |
ADJUSTMENT DISORDER |
2 |
| 811 |
ADRENAL INSUFFICIENCY |
2 |
| 812 |
ADULTERATED PRODUCT |
2 |
| 813 |
AGORAPHOBIA |
2 |
| 814 |
ALLERGIC REACTION TO EXCIPIENT |
2 |
| 815 |
AMINO ACID LEVEL INCREASED |
2 |
| 816 |
ANION GAP ABNORMAL |
2 |
| 817 |
ANXIETY DISORDER |
2 |
| 818 |
AORTIC VALVE INCOMPETENCE |
2 |
| 819 |
ASCITES |
2 |
| 820 |
AUTOIMMUNE THYROIDITIS |
2 |
| 821 |
BACTERIAL INFECTION |
2 |
| 822 |
BIPOLAR I DISORDER |
2 |
| 823 |
BLADDER SPASM |
2 |
| 824 |
BLOOD CREATINE INCREASED |
2 |
| 825 |
BLOOD DISORDER |
2 |
| 826 |
BLOOD IRON DECREASED |
2 |
| 827 |
BLOOD LOSS ANAEMIA |
2 |
| 828 |
BLOOD PRESSURE FLUCTUATION |
2 |
| 829 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
2 |
| 830 |
BLOOD PRESSURE SYSTOLIC DECREASED |
2 |
| 831 |
BLOOD THYROID STIMULATING HORMONE ABNORMAL |
2 |
| 832 |
BODY HEIGHT DECREASED |
2 |
| 833 |
BONE DISORDER |
2 |
| 834 |
BREAST CANCER |
2 |
| 835 |
BREAST DISORDER |
2 |
| 836 |
BRIEF RESOLVED UNEXPLAINED EVENT |
2 |
| 837 |
BRONCHIOLITIS |
2 |
| 838 |
CARDIAC FAILURE CONGESTIVE |
2 |
| 839 |
CARDIOMEGALY |
2 |
| 840 |
CARDIOVASCULAR DISORDER |
2 |
| 841 |
CATHETER SITE BRUISE |
2 |
| 842 |
CATHETER SITE DISCOLOURATION |
2 |
| 843 |
CATHETER SITE HAEMORRHAGE |
2 |
| 844 |
CATHETER SITE SWELLING |
2 |
| 845 |
CEREBRAL INFARCTION |
2 |
| 846 |
CHOLELITHIASIS |
2 |
| 847 |
CHOREA |
2 |
| 848 |
CHRONIC FATIGUE SYNDROME |
2 |
| 849 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
2 |
| 850 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
| 851 |
CLONUS |
2 |
| 852 |
COELIAC DISEASE |
2 |
| 853 |
COLITIS ULCERATIVE |
2 |
| 854 |
COLON CANCER |
2 |
| 855 |
COMA SCALE ABNORMAL |
2 |
| 856 |
COMPLICATION ASSOCIATED WITH DEVICE |
2 |
| 857 |
COMPLICATION OF DEVICE INSERTION |
2 |
| 858 |
COMPLICATION OF DEVICE REMOVAL |
2 |
| 859 |
CONDUCT DISORDER |
2 |
| 860 |
CONSCIOUSNESS FLUCTUATING |
2 |
| 861 |
CONVERSION DISORDER |
2 |
| 862 |
CONVULSION |
2 |
| 863 |
CORONAVIRUS INFECTION |
2 |
| 864 |
CRANIOFACIAL FRACTURE |
2 |
| 865 |
CUSHINGOID |
2 |
| 866 |
CYST RUPTURE |
2 |
| 867 |
CYSTIC FIBROSIS RELATED DIABETES |
2 |
| 868 |
DAYDREAMING |
2 |
| 869 |
DECREASED INTEREST |
2 |
| 870 |
DECUBITUS ULCER |
2 |
| 871 |
DEVELOPMENTAL DELAY |
2 |
| 872 |
DEVICE INFUSION ISSUE |
2 |
| 873 |
DEVICE OCCLUSION |
2 |
| 874 |
DEVICE POWER SOURCE ISSUE |
2 |
| 875 |
DEVICE USE ISSUE |
2 |
| 876 |
DIABETES MELLITUS |
2 |
| 877 |
DIABETES MELLITUS INADEQUATE CONTROL |
2 |
| 878 |
DISORGANISED SPEECH |
2 |
| 879 |
DRUG ADMINISTERED IN WRONG DEVICE |
2 |
| 880 |
DRUG EFFECT DELAYED |
2 |
| 881 |
DRUG EFFECT INCREASED |
2 |
| 882 |
DRUG EFFECT VARIABLE |
2 |
| 883 |
DRUG HALF-LIFE INCREASED |
2 |
| 884 |
DRUG LEVEL BELOW THERAPEUTIC |
2 |
| 885 |
DRUG LEVEL DECREASED |
2 |
| 886 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
2 |
| 887 |
DRUG SCREEN POSITIVE |
2 |
| 888 |
DRUG WITHDRAWAL CONVULSIONS |
2 |
| 889 |
DRY THROAT |
2 |
| 890 |
DUODENAL ULCER |
2 |
| 891 |
DYSGRAPHIA |
2 |
| 892 |
DYSPAREUNIA |
2 |
| 893 |
ECONOMIC PROBLEM |
2 |
| 894 |
ELECTROENCEPHALOGRAM ABNORMAL |
2 |
| 895 |
ELEVATED MOOD |
2 |
| 896 |
EMBEDDED DEVICE |
2 |
| 897 |
ENCEPHALITIS |
2 |
| 898 |
ERYTHEMA OF EYELID |
2 |
| 899 |
EXERCISE TOLERANCE DECREASED |
2 |
| 900 |
EXPOSURE TO SARS-COV-2 |
2 |
| 901 |
EXPOSURE TO TOXIC AGENT |
2 |
| 902 |
EXTRASYSTOLES |
2 |
| 903 |
FACE INJURY |
2 |
| 904 |
FACIAL PAIN |
2 |
| 905 |
FAECES DISCOLOURED |
2 |
| 906 |
FEBRILE NEUTROPENIA |
2 |
| 907 |
FEELING DRUNK |
2 |
| 908 |
FEELING OF BODY TEMPERATURE CHANGE |
2 |
| 909 |
FLUID INTAKE REDUCED |
2 |
| 910 |
FOAMING AT MOUTH |
2 |
| 911 |
FOOT FRACTURE |
2 |
| 912 |
FOREIGN BODY IN REPRODUCTIVE TRACT |
2 |
| 913 |
FRUSTRATION |
2 |
| 914 |
GALACTORRHOEA |
2 |
| 915 |
GASTRIC ULCER |
2 |
| 916 |
GASTROINTESTINAL HYPOMOTILITY |
2 |
| 917 |
GASTROINTESTINAL MOTILITY DISORDER |
2 |
| 918 |
GENDER DYSPHORIA |
2 |
| 919 |
GENERALISED OEDEMA |
2 |
| 920 |
GLOSSODYNIA |
2 |
| 921 |
HAEMATOCRIT DECREASED |
2 |
| 922 |
HAEMATOLOGICAL INFECTION |
2 |
| 923 |
HAEMATURIA |
2 |
| 924 |
HAEMODYNAMIC INSTABILITY |
2 |
| 925 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
2 |
| 926 |
HAEMORRHAGIC DIATHESIS |
2 |
| 927 |
HALLUCINATIONS, MIXED |
2 |
| 928 |
HEAD BANGING |
2 |
| 929 |
HEAVY MENSTRUAL BLEEDING |
2 |
| 930 |
HEPATITIS |
2 |
| 931 |
HOSPICE CARE |
2 |
| 932 |
HYPERCHOLESTEROLAEMIA |
2 |
| 933 |
HYPERMETABOLISM |
2 |
| 934 |
HYPERTHERMIA |
2 |
| 935 |
HYPERVOLAEMIA |
2 |
| 936 |
HYPOACUSIS |
2 |
| 937 |
HYPOKALAEMIA |
2 |
| 938 |
HYPOPHOSPHATAEMIA |
2 |
| 939 |
HYPOPNOEA |
2 |
| 940 |
ILEUS |
2 |
| 941 |
IMMUNE SYSTEM DISORDER |
2 |
| 942 |
IMPAIRED DRIVING ABILITY |
2 |
| 943 |
IMPERCEPTION |
2 |
| 944 |
INCORRECT STORAGE OF DRUG |
2 |
| 945 |
INFUSION SITE BRUISING |
2 |
| 946 |
INFUSION SITE EXTRAVASATION |
2 |
| 947 |
INFUSION SITE INFECTION |
2 |
| 948 |
INFUSION SITE PRURITUS |
2 |
| 949 |
INJECTION SITE DISCOMFORT |
2 |
| 950 |
INJECTION SITE EXTRAVASATION |
2 |
| 951 |
INJECTION SITE INDURATION |
2 |
| 952 |
INJECTION SITE VESICLES |
2 |
| 953 |
INSULIN-LIKE GROWTH FACTOR DECREASED |
2 |
| 954 |
INTENTION TREMOR |
2 |
| 955 |
INTENTIONAL MISUSE OF DRUG DELIVERY SYSTEM |
2 |
| 956 |
INTENTIONAL PRODUCT MISUSE TO CHILD |
2 |
| 957 |
INTERMITTENT EXPLOSIVE DISORDER |
2 |
| 958 |
INTRACRANIAL PRESSURE INCREASED |
2 |
| 959 |
JAUNDICE |
2 |
| 960 |
KIDNEY INFECTION |
2 |
| 961 |
KLEPTOMANIA |
2 |
| 962 |
LANGUAGE DISORDER |
2 |
| 963 |
LIGAMENT SPRAIN |
2 |
| 964 |
LIVEDO RETICULARIS |
2 |
| 965 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
2 |
| 966 |
LYMPHADENOPATHY |
2 |
| 967 |
MALIGNANT CATATONIA |
2 |
| 968 |
MALNUTRITION |
2 |
| 969 |
MANUFACTURING ISSUE |
2 |
| 970 |
MANUFACTURING MATERIALS ISSUE |
2 |
| 971 |
MASS |
2 |
| 972 |
MASTICATION DISORDER |
2 |
| 973 |
MEDICAL DEVICE SITE INFECTION |
2 |
| 974 |
MEGACOLON |
2 |
| 975 |
METABOLIC DISORDER |
2 |
| 976 |
METABOLIC SYNDROME |
2 |
| 977 |
MOANING |
2 |
| 978 |
MOTOR DYSFUNCTION |
2 |
| 979 |
MUCOUS STOOLS |
2 |
| 980 |
MUSCLE CONTRACTIONS INVOLUNTARY |
2 |
| 981 |
MUSCULOSKELETAL CHEST PAIN |
2 |
| 982 |
MUSCULOSKELETAL PAIN |
2 |
| 983 |
MYOCLONUS |
2 |
| 984 |
NAIL PICKING |
2 |
| 985 |
NEGATIVE THOUGHTS |
2 |
| 986 |
NEOPLASM MALIGNANT |
2 |
| 987 |
NEUROLOGICAL SYMPTOM |
2 |
| 988 |
NEUROMYOPATHY |
2 |
| 989 |
NO THERAPEUTIC RESPONSE |
2 |
| 990 |
NODAL RHYTHM |
2 |
| 991 |
OCULAR TOXICITY |
2 |
| 992 |
ORAL PRURITUS |
2 |
| 993 |
OROPHARYNGEAL DISCOMFORT |
2 |
| 994 |
OSTEOPOROSIS |
2 |
| 995 |
OTITIS MEDIA |
2 |
| 996 |
OTORRHOEA |
2 |
| 997 |
OXYGEN SATURATION ABNORMAL |
2 |
| 998 |
PANCREATITIS NECROTISING |
2 |
| 999 |
PARAESTHESIA ORAL |
2 |